Apr 29, 2025, 14:36
Eric K. Singhi: Dr. John Heymach from MD Anderson Cancer Center presents on BEAMION-Lung 1
Eric K. Singhi, Thoracic Medical Oncologist at MD Anderson Cancer Center, shared a post on X:
“Hot off the press—Our Dr. John Heymach from MD Anderson Cancer Center presents on BEAMION-Lung 1. Oral zongertinib 120 mg QD in previously-treated HER2+ mNSCLC:
ORR 71%
mPFS 12.4 mo
Intracranial ORR 41%
No ILD, only 1 patient w/ grade 3 diarrhea.”
“Zongertinib in Previously Treated HER2-Mutant Non–Small-Cell Lung Cancer”
Authors: John V. Heymach et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 29, 2025, 13:57
Apr 29, 2025, 13:42
Apr 29, 2025, 12:46
Apr 29, 2025, 11:58
Apr 29, 2025, 11:21
Apr 29, 2025, 11:13
Apr 29, 2025, 10:37
Apr 29, 2025, 10:28